Business, energy, technology, markets and global industry news from Business News Today

World Health Organization

Features & Analysis

Bayer-backed self-care research highlights referral, affordability and health literacy gaps

Bayer-backed research says self-care can ease health-system strain, but only with safeguards, affordable access and clear referral pathways.

Read More
Medical Devices & Diagnostics

Can CoSara’s 30-minute PCR platform close India’s tuberculosis testing gap? The decisive studies have begun

CoSara begins India clinical studies of Co-Diagnostics’ rapid tuberculosis PCR test, but assay clearance and real-world validation remain ahead.

Read More
Features & Analysis

Can emergency Ebola treatment centers close Africa’s outbreak response gap?

Find out how Samaritan’s Purse’s Ebola treatment deployment in Congo highlights urgent gaps in outbreak readiness and field care.

Read More
Features & Analysis

A rare disease policy shift just landed at the WHO. Could it change hemophilia care worldwide?

Find out how the WHO hemophilia resolution could reshape diagnosis, treatment access, prophylaxis and bleeding disorder care worldwide.

Read More
Pharma & Biotech

Why Gilead’s visceral leishmaniasis collaboration with WHO matters beyond drug donation

Gilead’s WHO pact targets kala-azar access, but diagnostics, treatment delivery and East Africa execution will decide the impact.

Read More
Features & Analysis

Is endometriosis diagnosis finally moving beyond surgery after years of missed symptoms?

Endometriosis testing is escaping the surgery-first era. Saliva, blood and imaging tools now face the harder test: clinical utility.

Read More
Pharma & Biotech

How Novartis Pharma AG is targeting the last untreated segment in malaria care

Discover how Novartis Pharma AG is targeting neonatal malaria with Coartem Baby and what WHO prequalification means for global access.

Read More
Pharma & Biotech

Why GC Biopharma’s BARYCELA approval in Guatemala matters beyond one Latin American market

GC Biopharma won Guatemala approval for BARYCELA. Read what this means for Latin America, vaccine supply strategy, and varicella market competition.

Read More